Genome Biologics

Developer of therapies for cardiovascular and cardiometabolic diseases

placeFrankfurt Am Main, Hesse, Germany calendar_todayFounded 2016 groups12 employees language genomebiologics.com

Registered entities

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Accelerator & incubator250%
Other / undisclosed125%
Coming soon